APPLICATION OF COMBINED CARDIOPROTECTIVE AGENTS TO PRESERVE ORGAN FUNCTION AND IMPROVE SURVIVAL DURING EXPERIMENTAL HEMORRHAGIC SHOCK
$1,911,650FY2016Department of the ArmyDOD
Huntington Medical Research Institutes, Pasadena CA
Huntington Medical Research Institutes, Pasadena CA